SCHEMBL271046

SCHEMBL271046

C[CH]C(C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3659788 1.00
SCHEMBL3401530 0.74 TSHR (0.47)
SCHEMBL3401523 0.74 TSHR (0.47)
SCHEMBL716528 0.73
SCHEMBL1791605 0.73
SCHEMBL7555690 0.73
SCHEMBL3041427 0.73
SCHEMBL343256 0.71
SCHEMBL83813 0.69
SCHEMBL5153609 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3749670-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA Univerzita Palackeho v Olomouci (CZ) 2020-12-16 EP claimed
WO-2019149295-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2019-08-08 WO claimed
EP-2958928-A1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) Bayer Pharma Aktiengesellschaft (DE) 2015-12-30 EP claimed
WO-2014128108-A1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-08-28 WO claimed
WO-2014111588-A2 USE OF A REINFORCED ANTI-SUN PROTECTION COMPOSITION IN PROTECTION AGAINST LONG UVA RAYS FOR PROTECTING ONESELF AGAINST HERPES ATTACKS INDUCED BY EXPOSURE TO THE SUN L'OREAL (FR) 2014-07-24 WO claimed
EP-2734180-A2 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES L'OREAL (FR) 2014-05-28 EP claimed
WO-2013010590-A1 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES L'OREAL (FR) 2013-01-24 WO claimed
WO-2013011094-A2 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES L'OREAL (FR) 2013-01-24 WO claimed
US-8063234-B2 Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-11-22 US claimed
US-20110201564-A1 SUBSTITUTED 7-SULFANYLMETHYL, 7-SULFINYLMETHYL AND 7-SULFONYLMETHYL INDOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-08-18 US claimed
EP-2300423-A1 SUBSTITUTED 7-SULFANYLMETHYL, 7-SULFINYLMETHYL AND 7-SULFONYLMETHYL INDOLES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-03-30 EP claimed
US-20100105744-A1 SUBSTITUTED 7-SULFANYLMETHYL-, 7-SULFINYLMETHYL- AND 7-SULFONYLMETHYLINDOLES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-29 US claimed
WO-2009156072-A1 SUBSTITUTED 7-SULFANYLMETHYL, 7-SULFINYLMETHYL AND 7-SULFONYLMETHYL INDOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-12-30 WO claimed
EP-1962846-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-09-03 EP claimed
EP-1899329-A1 PYRIMIDINE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS IRM LLC A Delware Limited Liability Company (BM) 2008-03-19 EP claimed
WO-2007059323-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-24 WO claimed
WO-2007005673-A1 PYRIMIDINE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2007-01-11 WO claimed
EP-1455741-A2 NOVEL DEVELOPER COMPONENTS Henkel Kommanditgesellschaft auf Aktien (DE) 2004-09-15 EP claimed
WO-2003053370-A2 NOVEL DEVELOPER COMPONENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-07-03 WO claimed
CN-117321141-A Solvent-free composition 日产化学株式会社 2023-12-29 CN disclosed
CN-117279980-A Triazine ring-containing polymer and composition for pattern formation 日产化学株式会社 2023-12-22 CN disclosed
CN-117279998-A Solvent-free composition 日产化学株式会社 2023-12-22 CN disclosed
CN-117255822-A Triazine ring-containing polymer and composition for pattern formation 日产化学株式会社 2023-12-19 CN disclosed
CN-117222691-A Triazine ring-containing polymer and film-forming composition containing same 日产化学株式会社 2023-12-12 CN disclosed
US-11795270-B2 Triazine ring-containing polymer and film forming composition containing same NISSAN CHEMICAL CORPORATION (JP) 2023-10-24 US disclosed
CN-116917399-A Composition for forming release layer and release layer 日产化学株式会社 2023-10-20 CN disclosed
US-20230190730-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT JAPAN TOBACCO INC. (JP) 2023-06-22 US disclosed
CN-113365742-B Composition for forming release layer for slit die coating and release layer 日产化学株式会社 2023-04-18 CN disclosed
CN-110945078-B Composition for forming release layer and release layer 日产化学株式会社 2023-03-31 CN disclosed
EP-4139308-A1 PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2023-03-01 EP disclosed
US-20230053411-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES BAYER AKTIENGESELLSCHAFT (DE) 2023-02-23 US disclosed
CN-110256418-B 1, 3-thiazol-2-yl substituted benzamides 拜耳公司 2023-01-20 CN disclosed
US-20230002555-A1 TRIAZINE RING-CONTAINING POLYMER AND FILM FORMING COMPOSITION CONTAINING SAME NISSAN CHEMICAL CORPORATION (JP) 2023-01-05 US disclosed
US-20220396666-A1 TRIAZINE RING-CONTAINING POLYMER AND FILM FORMING COMPOSITION CONTAINING SAME NISSAN CHEMICAL CORPORATION (JP) 2022-12-15 US disclosed
CN-115427876-A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element 日产化学株式会社 2022-12-02 CN disclosed
WO-2022225017-A1 SOLVENTLESS COMPOSITION 日産化学株式会社 2022-10-27 WO disclosed
CN-109963922-B Aldehyde scavenger and method for removing aldehyde 东曹株式会社 2022-09-23 CN disclosed
CN-115003505-A Composition for forming peeling layer for alkali glass and peeling layer 日产化学株式会社 2022-09-02 CN disclosed
CN-114599704-A Triazine ring-containing polymer and film-forming composition containing the same 日产化学株式会社 2022-06-07 CN disclosed
CN-114585665-A Triazine ring-containing polymer and film-forming composition containing the same 日产化学株式会社 2022-06-03 CN disclosed
EP-3997083-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE Idorsia Pharmaceuticals Ltd (CH) 2022-05-18 EP disclosed
EP-3740493-B1 INHIBTEURS DE L'INDOLEAMINE 2,3-DIOXYGÉNASE ET/OU DU TRYPTOPHANE DIOXYGÉNASE IDORSIA PHARMACEUTICALS LTD (CH) 2021-12-01 EP disclosed
WO-2021214315-A1 PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2021-10-28 WO disclosed
US-11142523-B2 1,3-thiazol-2-yl substituted benzamides BAYER AKTIENGESELLSCHAFT (DE) 2021-10-12 US disclosed
US-11130855-B2 Composition for forming release layer, and release layer NISSAN CHEMICAL CORPORATION (JP) 2021-09-28 US disclosed
CN-113365742-A Composition for forming release layer for slit die coating and release layer 日产化学株式会社 2021-09-07 CN disclosed
WO-2021149705-A1 COMPOSITION FOR FORMING RELEASE LAYER FOR ALKALI GLASS, AND RELEASE LAYER 日産化学株式会社 2021-07-29 WO disclosed
US-20210220357-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NERVE FIBER SENSITIZATION BAYER AKTIENGESELLSCHAFT (DE) 2021-07-22 US disclosed
US-20210220358-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NERVE FIBER SENSITIZATION BAYER AKTIENGESELLSCHAFT (DE) 2021-07-22 US disclosed
WO-2021079977-A1 TRIAZINE RING-CONTAINING POLYMER AND FILM-FORMING COMPOSITION CONTAINING SAME 日産化学株式会社 2021-04-29 WO disclosed
WO-2021079991-A1 TRIAZINE RING-CONTAINING POLYMER AND FILM-FORMING COMPOSITION CONTAINING SAME 日産化学株式会社 2021-04-29 WO disclosed
EP-3793553-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NERVE FIBER SENSITIZATION Bayer Aktiengesellschaft (DE) 2021-03-24 EP disclosed
EP-3793554-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NERVE FIBER SENSITIZATION Bayer Aktiengesellschaft (DE) 2021-03-24 EP disclosed
CN-112384213-A 1, 3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization 拜耳公司 2021-02-19 CN disclosed
CN-112334132-A 1, 3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization 拜耳公司 2021-02-05 CN disclosed
WO-2021005222-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE IDORSIA PHARMACEUTICALS LTD (CH) 2021-01-14 WO disclosed
US-20200405696-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE IDORSIA PHARMACEUTICALS LTD (CH) 2020-12-31 US disclosed
EP-3749670-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA Univerzita Palackeho v Olomouci (CZ) 2020-12-16 EP disclosed
EP-3740493-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE Idorsia Pharmaceuticals Ltd (CH) 2020-11-25 EP disclosed
CN-107207507-B 1, 3-thiazol-2-yl substituted benzamides 拜耳公司 2020-11-06 CN disclosed
WO-2020158521-A1 COMPOSITION FOR FORMING RELEASE LAYER FOR SLIT DIE COATING, AND RELEASE LAYER 日産化学株式会社 2020-08-06 WO disclosed
US-20200239679-A1 COMPOSITION FOR FORMING RELEASE LAYER, AND RELEASE LAYER NISSAN CHEMICAL CORPORATION (JP) 2020-07-30 US disclosed
US-20200131169-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES BAYER AKTIENGESELLSCHAFT (DE) 2020-04-30 US disclosed
US-20200101061-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT JAPAN TOBACCO INC. (JP) 2020-04-02 US disclosed
CN-110945078-A Composition for forming release layer and release layer 日产化学株式会社 2020-03-31 CN disclosed
US-20200061225-A1 ALDEHYDE SCAVENGER AND METHOD FOR REMOVING ALDEHYDES TOSOH CORPORATION (JP) 2020-02-27 US disclosed
EP-3609893-A1 PURINE DERIVATIVES FOR USE AS MEDICAMENT AND FOR USE IN TREATING NEURODEGENERATIVE OR NEURO-INFLAMMATORY DISORDERS Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA) (FR) 2020-02-19 EP disclosed
US-10472354-B2 1,3-thiazol-2-yl substituted benzamides BAYER AKTIENGESELLSCHAFT (DE) 2019-11-12 US disclosed
EP-3564334-A1 ALDEHYDE SCAVENGER AND ALDEHYDE REMOVAL METHOD Tosoh Corporation (JP) 2019-11-06 EP disclosed
WO-2019149295-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2019-08-08 WO disclosed
US-20190185466-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES BAYER AKTIENGESELLSCHAFT (DE) 2019-06-20 US disclosed
CN-105969543-B Flue dust cleaning agent after fire 江苏筑磊电子科技有限公司 2019-04-05 CN disclosed
US-10202369-B2 1,3-thiazol-2-yl substituted benzamides BAYER AKTIENGESELLSCHAFT (DE) 2019-02-12 US disclosed
US-10183937-B2 1,3-thiazol-2-yl substituted benzamides BAYER AKTIENGESELLSCHAFT (DE) 2019-01-22 US disclosed
US-10174016-B2 1,3-thiazol-2-yl substituted benzamides BEYER AKTIENGESELLSCHAFT (DE) 2019-01-08 US disclosed
EP-3406596-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS HIV INTEGRASE INHIBITOR Japan Tobacco Inc. (JP) 2018-11-28 EP disclosed
WO-2018189122-A1 PURINE DERIVATIVES FOR USE AS MEDICAMENT AND FOR USE IN TREATING NEURODEGENERATIVE OR NEURO-INFLAMMATORY DISORDERS COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2018-10-18 WO disclosed
US-20180265454-A1 Method for Producing 4-Oxoquinoline Compound JAPAN TOBACCO INC. (JP) 2018-09-20 US disclosed
CN-105385011-B A kind of TPV compositions and automobile collision preventing billot 嘉兴市博尔塑胶有限公司 2018-07-31 CN disclosed
US-20180118731-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES BAYER AKTIENGESELLSCHAFT (DE) 2018-05-03 US disclosed
EP-3303305-A1 2-(PHENYLOXY OR PHENYLTHIO)PYRIMIDINE DERIVATIVES AS HERBICIDES E. I. du Pont de Nemours and Company (US) 2018-04-11 EP disclosed
US-20180093980-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES EVOTEC AG (DE) 2018-04-05 US disclosed
EP-3294741-A1 5-SUBSTITUTED 7-[4-(2-PYRIDYL)PHENYLMETHYLAMINO]-3-ISOPROPYLPYRAZOLO4,3-D]PYRIMIDINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS Ustav Experimentalni Botaniky Av CR, V.V.I. (CZ) 2018-03-21 EP disclosed
US-20180072713-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES EVOTEC AG (DE) 2018-03-15 US disclosed
EP-3230281-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES Bayer Aktiengesellschaft (DE) 2017-10-18 EP disclosed
EP-2775352-B1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, AND ELECTROPHOTOGRAPHIC APPARATUS AND PROCESS CARTRIDGE EACH INCLUDING THE ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER CANON KK (JP) 2017-09-13 EP disclosed
EP-1389216-B1 AVERMECTINS SUBSTITUTED IN THE 4\"-POSITION HAVING PESTICIDAL PROPERTIES MERIAL INC (US) 2017-02-22 EP disclosed
WO-2016196606-A1 2-(PHENYLOXY OR PHENYLTHIO)PYRIMIDINE DERIVATIVES AS HERBICIDES E I DU PONT DE NEMOURS AND COMPANY (US) 2016-12-08 WO disclosed
WO-2016180380-A1 5-SUBSTITUTED 7-[4-(2-PYRIDYL)PHENYLMETHYLAMINO]-3-ISOPROPYLPYRAZOLO4,3-D]PYRIMIDINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I. (CZ) 2016-11-17 WO disclosed
CN-105969543-A Smoke dust cleaning agent after fire hazards 江苏筑磊电子科技有限公司 2016-09-28 CN disclosed
US-9389523-B2 Electrophotographic photosensitive member, and electrophotographic apparatus and process cartridge each including the electrophotographic photosensitive member CANON KABUSHIKI KAISHA (JP) 2016-07-12 US disclosed
US-9388171-B2 Serine/threonine kinase inhibitors GENETECH, INC. (US) 2016-07-12 US disclosed
WO-2016091776-A1 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES EVOTEC AG (DE) 2016-06-16 WO disclosed
CN-105385011-A TPV composition and automobile anti-collision strip Jiaxing boer plastic co ltd 2016-03-09 CN disclosed
CN-105330984-A TPV composition and automobile hand brake grip coating material ANHUI XIONGYA PLASTIC TECHNOLOGY CO LTD 2016-02-17 CN disclosed
US-20150299104-A1 METHOD FOR PRODUCING 4-OXOQUINOLINE COMPOUND JAPAN TOBACCO INC (JP) 2015-10-22 US disclosed
US-20150250911-A1 MALODOR COUNTERACTING COMPOSITIONS Givaudan, S.A. (CH) 2015-09-10 US disclosed
EP-1992607-B9 METHOD FOR PRODUCING 4-OXOQUINOLINE COMPOUND JAPAN TOBACCO INC (JP) 2015-07-01 EP disclosed
US-20150174117-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT JAPAN TOBACCO INC. 2015-06-25 US disclosed
EP-1992607-B1 METHOD FOR PRODUCING 4-OXOQUINOLINE COMPOUND JAPAN TOBACCO INC (JP) 2014-12-31 EP disclosed
US-20140255837-A1 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, AND ELECTROPHOTOGRAPHIC APPARATUS AND PROCESS CARTRIDGE EACH INCLUDING THE ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER CANON KABUSHIKI KAISHA (JP) 2014-09-11 US disclosed
EP-2775352-A2 ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, AND ELECTROPHOTOGRAPHIC APPARATUS AND PROCESS CARTRIDGE EACH INCLUDING THE ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER Canon Kabushiki Kaisha (JP) 2014-09-10 EP disclosed
CN-104035292-A ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, AND ELECTROPHOTOGRAPHIC APPARATUS AND PROCESS CARTRIDGE EACH INCLUDING THE ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER CANON KK 2014-09-10 CN disclosed
WO-2014111588-A2 USE OF A REINFORCED ANTI-SUN PROTECTION COMPOSITION IN PROTECTION AGAINST LONG UVA RAYS FOR PROTECTING ONESELF AGAINST HERPES ATTACKS INDUCED BY EXPOSURE TO THE SUN L'OREAL (FR) 2014-07-24 WO disclosed
EP-2734180-A2 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES L'OREAL (FR) 2014-05-28 EP disclosed
US-20140066453-A1 SERINE/THREONINE KINASE INHIBITORS GENENTECH, INC. (US) 2014-03-06 US disclosed
US-20130310595-A1 Method for Producing 4-Oxoquinoline Compound JAPAN TOBACCO INC. (JP) 2013-11-21 US disclosed
US-20130172344-A1 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS HIV INTEGRASE INHIBITOR JAPAN TOBACCO INC. 2013-07-04 US disclosed
EP-1888509-B1 BENZOYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2013-05-15 EP disclosed
US-8383819-B2 Method for producing 4-oxoquinoline compound JAPAN TOBACCO INC. (JP) 2013-02-26 US disclosed
WO-2013010590-A1 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES L'OREAL (FR) 2013-01-24 WO disclosed
WO-2013011094-A2 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES L'OREAL (FR) 2013-01-24 WO disclosed
US-8232401-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2012-07-31 US disclosed
US-8133851-B2 Heteroaroyl-substituted serine amides BASF SE (DE) 2012-03-13 US disclosed
US-20110318470-A1 Method For Improving Plant Health BASF SE (DE) 2011-12-29 US disclosed
US-8063234-B2 Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-11-22 US disclosed
EP-2368880-A1 6-(Heterocycle-Substituted Benzyl)-4-Oxoquinoline Compound and Use of the Same as HIV Integrase Inhibitor Japan Tobacco, Inc. (JP) 2011-09-28 EP disclosed
US-20110209253-A1 Method for Improving Plant Health BASF SE (DE) 2011-08-25 US disclosed
US-20110201564-A1 SUBSTITUTED 7-SULFANYLMETHYL, 7-SULFINYLMETHYL AND 7-SULFONYLMETHYL INDOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-08-18 US disclosed
EP-2348841-A1 METHOD FOR IMPROVING PLANT HEALTH BASF SE (DE) 2011-08-03 EP disclosed
EP-2348849-A1 METHOD FOR IMPROVING PLANT HEALTH BASF SE (DE) 2011-08-03 EP disclosed
EP-2300423-A1 SUBSTITUTED 7-SULFANYLMETHYL, 7-SULFINYLMETHYL AND 7-SULFONYLMETHYL INDOLES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-03-30 EP disclosed
US-7879761-B2 Herbicides; 1-{Methylcarbamoyl-[(1-methyl-3-trifluoromethyl-1H-pyrazol-4-carbonyl)amino]methyl}-allyl acetate; acylation of keto compounds and reduction of the ketone, or the serine derivative is reacted with a heteroaryl acid and then with a secondary or tertiary amine BASF AKTIENGESELLSCHAFT (DE) 2011-02-01 US disclosed
US-7872004-B2 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2011-01-18 US disclosed
EP-2272516-A2 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor Japan Tobacco, Inc. (JP) 2011-01-12 EP disclosed
EP-2231665-A2 NOVEL COMPOSITIONS AND METHODS OF USE Ardea Biosciences, Inc. (US) 2010-09-29 EP disclosed
EP-2121583-B1 HETEROARYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2010-09-22 EP disclosed
US-7786046-B2 Benzoyl-substituted serineamides BASF AKTIENGESELLSCHAFT (DE) 2010-08-31 US disclosed
US-7745459-B2 Quinolizinone compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2010-06-29 US disclosed
US-7732416-B2 For protecting plants against parasitic feeding pests; also against the infestation of pets, especially cats and dogs, by fleas, ticks and nematodes; pesticides for crop protection MERIAL LIMITED (US) 2010-06-08 US disclosed
WO-2010049405-A1 METHOD FOR IMPROVING PLANT HEALTH BASF SE (DE) 2010-05-06 WO disclosed
WO-2010049414-A1 METHOD FOR IMPROVING PLANT HEALTH BASF SE (DE) 2010-05-06 WO disclosed
US-20100105744-A1 SUBSTITUTED 7-SULFANYLMETHYL-, 7-SULFINYLMETHYL- AND 7-SULFONYLMETHYLINDOLES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-29 US disclosed
US-20100099568-A1 Heteroaroyl-Substituted Serine Amides BASF SE (DE) 2010-04-22 US disclosed
US-7700500-B2 Durable hydrophilic treatment for a biodegradable polymeric substrate KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-04-20 US disclosed
EP-1564210-B9 4-OXOQUINOLINE COMPOUNDS AND UTILIZATION THEREOF AS HIV INTEGRASE INHIBITORS JAPAN TOBACCO INC (JP) 2010-03-31 EP disclosed
EP-2161258-A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor Japan Tabacco Inc. (JP) 2010-03-10 EP disclosed
WO-2009156072-A1 SUBSTITUTED 7-SULFANYLMETHYL, 7-SULFINYLMETHYL AND 7-SULFONYLMETHYL INDOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-12-30 WO disclosed
EP-2121583-A1 HETEROARYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2009-11-25 EP disclosed
US-7605134-B2 Pesticides MERIAL LIMITED (US) 2009-10-20 US disclosed
EP-1564210-B1 4-OXOQUINOLINE COMPOUNDS AND UTILIZATION THEREOF AS HIV INTEGRASE INHIBITORS JAPAN TOBACCO INC (JP) 2009-09-16 EP disclosed
US-20090215628-A1 Benzoyl-Substituted Alanines BASF SE (DE) 2009-08-27 US disclosed
US-20090186766-A1 Heteroaroyl-Substituted Alanines with a Herbicidal Action BASF SE (DE) 2009-07-23 US disclosed
WO-2009089263-A2 NOVEL COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES INC. (US) 2009-07-16 WO disclosed
US-7514205-B2 Composition for forming antireflection film, laminate, and method for forming resist pattern JSR CORPORATION (JP) 2009-04-07 US disclosed
EP-2033954-A1 6-(HETEROCYCLE-SUBSTITUTED BENZYL)-4-OXOQUINOLINE COMPOUND AND USE OF THE SAME AS HIV INTEGRASE INHIBITOR Japan Tobacco, Inc. (JP) 2009-03-11 EP disclosed
US-20090054240-A1 Heteroaroyl-substituted Alanines BASF SE (DE) 2009-02-26 US disclosed
EP-2027095-A1 HETEROAROYL-SUBSTITUTED ALANINES WITH A HERBICIDAL ACTION BASF SE (DE) 2009-02-25 EP disclosed
EP-2024327-A1 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2009-02-18 EP disclosed
US-20090036311-A1 Benzoyl-Substituted Alanines BASF SE (DE) 2009-02-05 US disclosed
US-20090036684-A1 METHOD FOR PRODUCING 4-OXOQUINOLINE COMPOUND SHIONOGI & CO., LTD. (JP) 2009-02-05 US disclosed
EP-1992607-A1 METHOD FOR PRODUCING 4-OXOQUINOLINE COMPOUND Japan Tobacco, Inc. (JP) 2008-11-19 EP disclosed
EP-1987015-A2 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2008-11-05 EP disclosed
EP-1987008-A2 HETEROAROYL-SUBSTITUTED ALANINES BASF SE (DE) 2008-11-05 EP disclosed
EP-1962846-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-09-03 EP disclosed
US-20080207618-A1 6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor JAPAN TOBACCO INC. (JP) 2008-08-28 US disclosed
US-20080200338-A1 Heteroaroyl-Substituted Serineamides BASF AKTIENGESELLSCHAFT (DE) 2008-08-21 US disclosed
US-20080200542-A1 Benzoyl-Substituted Serineamides BASF AKTIENGESELLSCHAFT (DE) 2008-08-21 US disclosed
WO-2008084073-A1 HETEROARYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2008-07-17 WO disclosed
WO-2008084070-A1 BENZOYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2008-07-17 WO disclosed
EP-1899329-A1 PYRIMIDINE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS IRM LLC A Delware Limited Liability Company (BM) 2008-03-19 EP disclosed
CN-100375742-C 4-oxoquinoline compounds and utilization thereof as HIV integrase inhibitors JAPAN TOBACCO INC (JP) 2008-03-19 CN disclosed
EP-1888532-A1 HETEROAROYL-SUBSTITUTED SERINE AMIDES BASF AKTIENGESELLSCHAFT (DE) 2008-02-20 EP disclosed
EP-1888509-A1 BENZOYL-SUBSTITUTED SERINE AMIDES BASF AKTIENGESELLSCHAFT (DE) 2008-02-20 EP disclosed
WO-2007134984-A1 HETEROAROYL-SUBSTITUTED ALANINES WITH A HERBICIDAL ACTION BASF SE (DE) 2007-11-29 WO disclosed
WO-2007134971-A1 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2007-11-29 WO disclosed
WO-2007093529-A2 HETEROAROYL-SUBSTITUTED ALANINES BASF SE (DE) 2007-08-23 WO disclosed
WO-2007093539-A2 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2007-08-23 WO disclosed
WO-2007059323-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-24 WO disclosed
WO-2007059113-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-24 WO disclosed
US-7176220-B2 4-oxoquinoline compound and use thereof as pharmaceutical agent JAPAN TOBACCO INC. (JP) 2007-02-13 US disclosed
WO-2007005673-A1 PYRIMIDINE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2007-01-11 WO disclosed
WO-2006125688-A1 BENZOYL-SUBSTITUTED SERINE AMIDES BASF AKTIENGESELLSCHAFT (DE) 2006-11-30 WO disclosed
WO-2006125687-A1 HETEROAROYL-SUBSTITUTED SERINE AMIDES BASF AKTIENGESELLSCHAFT (DE) 2006-11-30 WO disclosed
US-20060223008-A1 Composition for forming antireflection film, laminate, and method for forming resist pattern JSR CORPORATION (JP) 2006-10-05 US disclosed
US-20060217413-A1 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. 2006-09-28 US disclosed
EP-1703327-A2 Composition for forming antireflection film, laminate, and method for forming resist pattern JSR Corporation (JP) 2006-09-20 EP disclosed
US-20060105970-A1 Avermectins substituted in the 4\"-position having pesticidal properties SYNGENTA CROP PROTECTION, INC. 2006-05-18 US disclosed
US-20060084665-A1 Quinolizinone compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2006-04-20 US disclosed
WO-2006038001-A1 AMINOPYRIMIDINE DERIVATIVES AS JNK INHIBITORS CELLTECH R & D LIMITED (GB) 2006-04-13 WO disclosed
CN-1692101-A 4-oxoquinoline compounds and utilization thereof as HIV integrase inhibitors JAPAN TOBACCO INC (JP) 2005-11-02 CN disclosed
US-20050239819-A1 4-Oxoquinoline compounds and utilization thereof as hiv integrase inhibitors SHIONOGI & CO., LTD. (JP) 2005-10-27 US disclosed
EP-1575842-A2 DURABLE HYDROPHILIC TREATMENT FOR A BIODEGRADABLE POLYMERIC SUBSTRATE KIMBERLY-CLARK WORLDWIDE, INC. (US) 2005-09-21 EP disclosed
EP-1564210-A1 4-OXOQUINOLINE COMPOUNDS AND UTILIZATION THEREOF AS HIV INTEGRASE INHIBITORS JAPAN TOBACCO INC. (JP) 2005-08-17 EP disclosed
EP-1455741-A2 NOVEL DEVELOPER COMPONENTS Henkel Kommanditgesellschaft auf Aktien (DE) 2004-09-15 EP disclosed
WO-2004058314-A2 DURABLE HYDROPHILIC TREATMENT FOR A BIODEGRADABLE POLYMERIC SUBSTRATE KIMBERLY-CLARK WORLDWIDE, INC. (US) 2004-07-15 WO disclosed
US-20040127123-A1 Durable hydrophilic treatment for a biodegradable polymeric substrate KIMBERLY-CLARK WORLDWIDE, INC. 2004-07-01 US disclosed
CN-1153867-C Durable hydrophilic coatings for porous hydrophobic polymeric substrates - 2004-06-16 CN disclosed
WO-2003053370-A2 NOVEL DEVELOPER COMPONENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-07-03 WO disclosed
US-5945175-A EXPOSING POROUS HYDROPHOBIC SUBSTRATE TO FIELD OF REACTIVE SPECIES, TREATING WITH HYDROPHILIC POLYMER KIMBERLY-CLARK WORLDWIDE, INC. (US) 1999-08-31 US disclosed
CN-1222207-A Durable hydrophilic coatings for porous hydrophobic polymeric substrates KIMBERLY CLARK CO (US) 1999-07-07 CN disclosed
EP-0904446-A1 DURABLE HYDROPHILIC COATING FOR A POROUS HYDROPHOBIC POLYMER SUBSTRATE Kimberly-Clark Worldwide, Inc. (US) 1999-03-31 EP disclosed
US-5814567-A POLYSACCHARIDE COATING FOR DISPOSABLE ABSORBENT PRODUCTS KIMBERLY-CLARK WORLDWIDE, INC. (US) 1998-09-29 US disclosed
WO-1997047801-A1 DURABLE HYDROPHILIC COATING FOR A POROUS HYDROPHOBIC POLYMER SUBSTRATE KIMBERLY-CLARK WORLDWIDE, INC. (US) 1997-12-18 WO disclosed
EP-0540540-B1 VATERITE AND PRODUCTION METHOD LHOIST RECH & DEV SA (BE) 1994-09-28 EP disclosed
US-5290353-A Vaterite and production method LHOIST RECHERCHE ET DEVELOPPEMENT S.A. (BE) 1994-03-01 US disclosed
US-5266673-A Compatibilizer for polymer blends and alloys MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1993-11-30 US disclosed
EP-0540540-A1 VATERITE AND PRODUCTION METHOD. LHOIST RECH & DEV SA (BE) 1993-05-12 EP disclosed
EP-0530442-A1 Process for producing a hydroxy-substituted poly (phenylene ether) resin MITSUBISHI CHEMICAL CORPORATION (JP) 1993-03-10 EP disclosed
WO-1992001629-A1 VATERITE AND PRODUCTION METHOD LHOIST RECHERCHE ET DEVELOPPEMENT S.A. (BE) 1992-02-06 WO disclosed
US-4151294-A Alkynols and process for their preparation MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1979-04-24 US disclosed
US-4151294-A Alkynols and process for their preparation MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1979-04-24 US disclosed